Company intelligence / Profile preview

BRI International

Arlington, Virginia, United States

Ownership: Private
Development stage: Other

Overview

BRI International was a prominent international contract research organization (CRO) that specialized in providing regulatory and clinical drug development services to the pharmaceutical and biotechnology industries. Founded in the early 1990s and headquartered in Arlington, Virginia, the company established a significant global presence with offices across North America, Europe, and Asia. BRI International was recognized for its expertise in managing complex clinical trials and navigating international regulatory requirements. In 1996, the company was acquired by Quintiles Transnational Corp (now part of IQVIA) in a strategic move that significantly expanded Quintiles' global reach and service capabilities.

Industry: Contract Research Organization

Beyond the preview

Go deeper on BRI International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BRI International.

Explore the full profile